Kirill Kosilov

428 total citations
49 papers, 333 citations indexed

About

Kirill Kosilov is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Kirill Kosilov has authored 49 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Urology, 28 papers in Rheumatology and 27 papers in Epidemiology. Recurrent topics in Kirill Kosilov's work include Urinary Bladder and Prostate Research (38 papers), Pelvic floor disorders treatments (27 papers) and Urinary Tract Infections Management (21 papers). Kirill Kosilov is often cited by papers focused on Urinary Bladder and Prostate Research (38 papers), Pelvic floor disorders treatments (27 papers) and Urinary Tract Infections Management (21 papers). Kirill Kosilov collaborates with scholars based in Russia. Kirill Kosilov's co-authors include and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Sexual Medicine and International Journal for Quality in Health Care.

In The Last Decade

Kirill Kosilov

47 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirill Kosilov Russia	12	260	207	134	52	40	49	333
H. M. Duffin United Kingdom	10	175 0.7×	299 1.4×	105 0.8×	6 0.1×	15 0.4×	16	403
Jonne T.H. Prins Netherlands	10	61 0.2×	27 0.1×	76 0.6×	110 2.1×	166 4.2×	20	417
Mattea Romano Italy	8	16 0.1×	51 0.2×	24 0.2×	56 1.1×	122 3.0×	10	361
Marcianna McCabe United States	8	96 0.4×	26 0.1×	17 0.1×	20 0.4×	126 3.1×	9	394
Susan H. Oakley United States	12	29 0.1×	127 0.6×	21 0.2×	18 0.3×	70 1.8×	21	311
A. Tsakiris Greece	9	48 0.2×	29 0.1×	20 0.1×	244 4.7×	259 6.5×	23	431
Yeva Sahakyan Canada	9	27 0.1×	28 0.1×	41 0.3×	4 0.1×	8 0.2×	30	247
Sidsel Boie Denmark	9	74 0.3×	16 0.1×	4 0.0×	59 1.1×	85 2.1×	18	286
Xiaoyi Shan United States	10	40 0.2×	12 0.1×	46 0.3×	30 0.6×	3 0.1×	14	289
Jennifer Williams United States	6	53 0.2×	11 0.1×	12 0.1×	44 0.8×	120 3.0×	9	285

Countries citing papers authored by Kirill Kosilov

Since Specialization

Citations

This map shows the geographic impact of Kirill Kosilov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirill Kosilov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirill Kosilov more than expected).

Fields of papers citing papers by Kirill Kosilov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirill Kosilov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirill Kosilov. The network helps show where Kirill Kosilov may publish in the future.

No nodes

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kosilov, Kirill, et al.. (2021). Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients. Asian journal of urology. 9(1). 42–50. 6 indexed citations

Kosilov, Kirill, et al.. (2021). ADHERENCE TO INTERACTIVE COMMUNICATIONS AND SELF-ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN MEDICAL UNIVERSITY STUDENTS. 12(3). 55–69. 1 indexed citations

Kosilov, Kirill, et al.. (2021). Cognitive status and health-related quality of life for medical students. SHILAP Revista de lepidopterología. 8(1). 85–96. 1 indexed citations

Kosilov, Kirill, et al.. (2020). SELF-ASSESSMENT OF PHYSICAL CHARACTERISTICS OF QUALITY OF LIFE, MORBIDITY, SOCIO-ECONOMIC STATUS AND ACADEMIC PERFORMANCE OF RUSSIAN AND CHINESE MEDICAL STUDENTS IN THE NEIGHBORING TERRITORIES OF THE FAR EAST. Social Aspects of Population Health. 66(2). 2–2.

Kosilov, Kirill, et al.. (2020). Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride. Prostate International. 8(2). 78–84. 10 indexed citations

Kosilov, Kirill, et al.. (2019). ANALYSIS OF SELF-EVALUATION OF HEALTH AND MORBIDITY AMONG SENIOR STUDENTS OF MEDICAL AND HUMANITARIAN SPECIALTIES. Social Aspects of Population Health. 65(4). 2–2. 3 indexed citations

Kosilov, Kirill, et al.. (2019). Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 4. 100086–100086. 3 indexed citations

Kosilov, Kirill, et al.. (2018). The optimal duration of alarm therapy use in children with primary monosymptomatic nocturnal enuresis. Journal of Pediatric Urology. 14(5). 447.e1–447.e6. 15 indexed citations

Kosilov, Kirill, et al.. (2018). Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence. International Neurourology Journal. 22(1). 41–50. 14 indexed citations

10.

Kosilov, Kirill, et al.. (2017). Comprehensive Assessment of Compliance with Antimuscarinic Drug Treatment in the Case of Urge Urinary Incontinence of Older Patients. Current Aging Science. 10(2). 149–156. 1 indexed citations

11.

Kosilov, Kirill, et al.. (2017). Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage. The Aging Male. 21(2). 121–129. 22 indexed citations

12.

Kosilov, Kirill, et al.. (2017). Health-related quality of life's dependence on socio-economic status and demographic characteristics among men with benign prostatic hyperplasia. Andrologia. 50(3). e12892–e12892. 4 indexed citations

13.

Kosilov, Kirill, et al.. (2017). A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence. Arab Journal of Urology. 15(4). 372–379. 2 indexed citations

14.

Kosilov, Kirill, et al.. (2016). Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People. Current Urology. 9(3). 124–131. 5 indexed citations

15.

Kosilov, Kirill, et al.. (2016). Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms. International Neurourology Journal. 20(3). 240–249. 7 indexed citations

16.

Kosilov, Kirill, et al.. (2015). A randomized, controlled trial of effectiveness and safety of management of OAB symptoms in elderly men and women with standard-dosed combination of solifenacin and mirabegron. Archives of Gerontology and Geriatrics. 61(2). 212–216. 28 indexed citations

17.

Kosilov, Kirill, et al.. (2015). Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia. American Journal of Men s Health. 10(2). 157–163. 15 indexed citations

18.

Kosilov, Kirill, et al.. (2014). Decrease of Risk of Developing Symptoms of OAB in Elderly Men and Women Treated with Loop Diuretic for Hypertensive Disease Using Solifenacin. Current Aging Science. 7(3). 229–234. 5 indexed citations

19.

Kosilov, Kirill, et al.. (2014). Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin. The Aging Male. 18(1). 44–48. 20 indexed citations

20.

Kosilov, Kirill, et al.. (2013). Therapeutic effect Consolidation in overactive bladder treatment in elderly women by the use of increased antimuscarinic dosages. Sovremennye tehnologii v medicine. 5(4). 78–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact